Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29365624 | 1.00 | MAPT (0.32) | MAPTTP53AR | |
| Hydrochloric Acid SCHEMBL2833170 | 0.99 | MAPT (0.32) | MAPTTP53 | |
| SCHEMBL15612708 | 0.87 | HPGD (0.32) | MAPT | |
| SCHEMBL29861617 | 0.87 | HPGD (0.32) | MAPT | |
| SCHEMBL1195613 | 0.87 | ALOX5 (0.36) | — | |
| SCHEMBL1244265 | 0.87 | SMN1; SMN2 (0.33) | MAPT | |
| SCHEMBL16390254 | 0.86 | HPGD (0.35) | MAPT | |
| SCHEMBL34469514 | 0.85 | ADRA1D (0.34) | — | |
| SCHEMBL2587303 | 0.85 | ADRA1D (0.34) | — | |
| SCHEMBL15525571 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080282-A | Preparation method of cyclic polyolefin | — | 2026-05-26 | — | — | CN | claimed |
| US-12612352-B2 | Process for preparing perfuming intermediate | FIRMENICH SA (CH) | 2026-04-28 | — | — | US | claimed |
| EP-3411046-B1 | RAPAGLUTINS, NOVEL INHIBITORS OF GLUT AND USE THEREOF | UNIV JOHNS HOPKINS (US) | 2025-07-16 | — | — | EP | claimed |
| US-20250179091-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | VERTEX PHARMA (US) | 2025-06-05 | — | — | US | claimed |
| CN-117229451-B | Polynorbornene-based crosslinked anion exchange membrane and preparation method and application thereof | 北京清玮膜科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119569997-A | Ionic polynorbornene crosslinked anion exchange membrane and preparation method and application thereof | 北京清玮膜科技有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119219898-A | Preparation method of degradable recycled plastic | 浙江大学 | 2024-12-31 | — | — | CN | claimed |
| US-20240368068-A1 | PROCESS FOR PREPARING PERFUMING INTERMEDIATES | FIRMENICH SA (CH) | 2024-11-07 | — | — | US | claimed |
| CN-118702842-A | Preparation method of liquid styrene-butadiene rubber | 青岛科技大学 | 2024-09-27 | — | — | CN | claimed |
| WO-2024186647-A1 | METHODS FOR CONVERTING POLYVINYL CHLORIDE TO SMALLER MOLECULES USING OLEFIN CROSS METATHESIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-09-12 | — | — | WO | claimed |
| US-7550607-B2 | Method of preparation of heterocyclic molecules with pharmaceutical, pharmaceutical excipient, cosmeceutical, agrochemical and industrial uses | AUSPEX PHARMACEUTICAL, INC. (US) | 2009-06-23 | — | — | US | claimed |
| US-7534917-B1 | Method of producing dicarboxylic acids | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 2009-05-19 | — | — | US | claimed |
| US-20080227851-A1 | LAULIMALIDE AND LAULIMALIDE ANALOGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2008-09-18 | — | — | US | claimed |
| EP-1935893-A1 | TOTAL SYNTHESIS OF PLADIENOLIDE B AND PLADIENOLIDE D | Eisai R&D Management Co., Ltd. (JP) | 2008-06-25 | — | — | EP | claimed |
| US-20080021226-A1 | Process for total synthesis of pladienolide B and pladienolide D | EISAI R&D MANAGEMENT CO., LTD. | 2008-01-24 | — | — | US | claimed |
| EP-1594835-A4 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | AUSPEX PHARMACEUTICALS INC (US) | 2007-05-02 | — | — | EP | claimed |
| US-20060173199-A1 | Method of preparation of heterocyclic molecules with pharmaceutical, pharmaceutical excipient, cosmeceutical, agrochemical and industrial uses | HONG BORCHERNG | 2006-08-03 | — | — | US | claimed |
| US-20060035822-A1 | Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases | ARRAY BIOPHARMA INC. | 2006-02-16 | — | — | US | claimed |
| EP-1594835-A2 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | Auspex Pharmaceuticals, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| WO-2004064745-A2 | METHOD OF PREPARATION OF HETEROCYCLIC MOLECULES WITH PHARMACEUTICAL PHARMACEUTICAL EXCIPIENT COSMECEUTICAL AGROCHEMICAL AND INDUSTRIAL USES | AUSPEX PHARMACEUTICALS, INC. (US) | 2004-08-05 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080227851-A1 | LAULIMALIDE AND LAULIMALIDE ANALOGS | SSB, LPXN, LTA | MAPT 4137/4885TP53 3013/4885AR 4444/4885 |
| US-12612352-B2 | Process for preparing perfuming intermediate | CBR1, CYP2E1, CBR3 | MAPT 4509/4885TP53 3815/4885AR 4122/4885 |
| US-20250179091-A1 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | CFTR, SCNN1G, SCNN1B | MAPT 4877/4885TP53 3907/4885AR 4693/4885 |
| US-20060173199-A1 | Method of preparation of heterocyclic molecules with pharmaceutical, pharmaceutical excipient, cosmeceutical, agrochemical and industrial uses | LSS, DHPS, CYP51A1 | MAPT 2419/4885TP53 994/4885AR 2935/4885 |
| US-20240368068-A1 | PROCESS FOR PREPARING PERFUMING INTERMEDIATES | POR, PPOX, ACLY | MAPT 3596/4885TP53 3282/4885AR 4820/4885 |
| US-20080021226-A1 | Process for total synthesis of pladienolide B and pladienolide D | TPD52L2, CYP8B1, HPD | MAPT 4788/4885TP53 547/4885AR 1006/4885 |
| US-20060035822-A1 | Cyclosporin analogs for the treatment of immunoregulatory disorders and respiratory diseases | TSLP, CHP1, IL2 | MAPT 4573/4885TP53 1498/4885AR 4262/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.